हिंदी में पढ़ें

pharmaceutical

South Korea's pharmaceutical, biotechnology exports surge 55% in H1

South Korea's pharmaceutical, biotechnology exports surge 55% in H1

Sat, Jun 29, 2024

In the first six months of the year, the country exported 4.5 trillion won ($3.26 billion) worth of pharmaceutical and biotechnologies, up 55 per cent from 2.9 trillion won (about $2.09 billion) for the same period last year, according to the data from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.

Dr Reddy's Laborataries signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection

Dr Reddy's Laborataries signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection

Wed, Jun 12, 2024

Dr Reddy's Laboratories Inc and US-based Ingenus Pharmaceuticals, LLC have entered into license agreement to commercialise cancer-treating Cyclophosphamide injection.

Orchid Pharma gets DCGI nod to market antibiotic drug combination

Orchid Pharma gets DCGI nod to market antibiotic drug combination

Thu, Jun 06, 2024

The Drug Controller General of India (DCGI) has granted permission to manufacture and market the finished dosage form of Cefepime and Enmetazobactam as a dry powder injectable, the drug firm said in a statement.

TRENDING NOW

Pharma stocks fall sharply as US drug pricing investigation nears completion

Pharma stocks fall sharply as US drug pricing investigation nears completion

Fri, Nov 04, 2016

Media reports suggest that the US Congress investigation into price hikes, that began in October 2014, may be nearing completion, culminating into charges of price collusion against companies / individuals by the year end.

Jubilant Life Sciences gains 8.53% on USFDA drug approval

Jubilant Life Sciences gains 8.53% on USFDA drug approval

Mon, Oct 03, 2016

Jubilant Life Sciences rose over 8% on BSE during opening trade on Monday after the company received USFDA approval for its RUBY-FILL- Rubidium 82 Generator and elution system.

Dr Reddy gets listed on Dow Jones sustainability indices 2016

Dr Reddy gets listed on Dow Jones sustainability indices 2016

Tue, Sep 13, 2016

G V Prasad, Co-chairman and CEO of Dr Reddy's Laboratories said,” This listing has earned us the trust and respect of all stakeholders we serve. I see our inclusion in the Dow Jones indices as another validation of our commitment to sustainability in all aspects of our business.”

Modi gives final nod to woo foreign investors into India

Modi gives final nod to woo foreign investors into India

Thu, Sep 01, 2016

The Union Cabinet chaired by Modi, gave its nod to major changes made to the FDI rules, including hiking foreign investment to 100% in the defence sector.

EU regulator to review Mylan-Biocon's cancer drug; shares hit new high

EU regulator to review Mylan-Biocon's cancer drug; shares hit new high

Fri, Aug 26, 2016

Biocon informed that EMA has accepted for review of Mylan's market authorization application (MAA) for a proposed biosimilar Trastuzumab, which is used to treat certain breast and gastric cancer.

Cipla Management restructuring looks positive, analysts say

Cipla Management restructuring looks positive, analysts say

Fri, Aug 19, 2016

Last week, the company reported a 43.74% drop in consolidated net profit at Rs 365.24 crore for the quarter ended on June 30, 2016.

Wockhardt net down 83% at Rs 16 crore; India business grows 10%

Wockhardt net down 83% at Rs 16 crore; India business grows 10%

Sat, Aug 13, 2016

The company’s India business grew by 10% in the quarter led by continued new products launches and focused strategies on various therapies, the company said in a notification to BSE. In April-June, 11 new projects were launched in India.

Glenmark Pharma net profit rise 24%; Europe segment major contributor

Glenmark Pharma net profit rise 24%; Europe segment major contributor

Fri, Aug 12, 2016

Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals said, “In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam.

Govt 'radically liberalises' the FDI regime

Govt 'radically liberalises' the FDI regime

Mon, Jun 20, 2016

The government's latest amendements in FDI policy are aimed to provide ease of doing business in the country which will result in increase in FDI inflows leading to rise in investment, incomes and employment.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x